Table 2.
Subset name | Phenotype | Greatest abundance | Key effectors | Roles in the decidua | |
---|---|---|---|---|---|
ILC1 | dNK cells | CD56bright CD16−
KIR++/− CD9+ Tbet+ Eomes+ |
Early pregnancy | Perforin Granzyme B Granulysin Cytokines |
Tolerance Trophoblast invasion Tissue remodeling Antiviral immunity |
Non-cytotoxic ILC1 | CD56−CD127−
CD117−Tbet+ Eomes- |
Early pregnancy | IFN-γ | Defense against intracellular bacteria and parasitic infection Allergy |
|
ILC2 | CD56−CD127+ CD161+Tbet− | Late pregnancy | IL-4, IL-5, IL-13, IL-22 | Tolerance Tissue repair Homeostasis | |
ILC3 | NCR+ | CD127+CD117+NCR+ | Early pregnancy | IL-8, IL-22, GM-CSF | Tissue remodeling Neutrophil recruitment and activation |
NCR− | CD127+CD117+NCR− | Early pregnancy | IL-17A, TNFα | Renewal of NCR+ population through ILC3 plasticity | |
LTi-like | Defined by RORγt expression | Early pregnancy | IL-17A, TNFα | Tissue remodeling Recruitment of other immune cells |
dNK cells, decidual natural killer cells; Eomes, eomesodermin; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL-, interleukin-; ILC, innate lymphoid cells; KIR, killer-cell immunoglobulin-like receptors; LTi, lymphoid tissue inducer, NCR, natural cytotoxic receptor; RORγt, RAR-related orphan gamma receptor; T-bet, T-box expressed in T cells; TNF, tumor necrosis factor.